WST
West Pharmaceutical Services Inc
NYSE: WST · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$297.59
+0.76% today
Updated 2026-04-30
Market cap
$20.64B
P/E ratio
39.05
P/S ratio
6.41x
EPS (TTM)
$7.48
Dividend yield
0.28%
52W range
$202 – $322
Volume
0.9M
West Pharmaceutical Services Inc (WST) Financial statements
SEC filings — annual and quarterly data.
Profit margin
16.90%
Operating margin
21.70%
ROE
19.10%
ROA
11.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $913.30M | $67.10M | 28.67% | 11.57% | 7.35% |
| 2007 | $1.02B | $70.70M | 28.61% | 11.08% | 6.93% |
| 2008 | $1.05B | $86.00M | 28.79% | 11.85% | 8.18% |
| 2009 | $1.06B | $72.60M | 28.76% | 10.04% | 6.88% |
| 2010 | $1.10B | $65.30M | 28.75% | 9.60% | 5.91% |
| 2011 | $1.19B | $75.50M | 28.43% | 9.72% | 6.33% |
| 2012 | $1.27B | $80.70M | 30.62% | 10.78% | 6.37% |
| 2013 | $1.37B | $112.30M | 31.77% | 11.87% | 8.21% |
| 2014 | $1.42B | $127.10M | 31.50% | 12.80% | 8.94% |
| 2015 | $1.40B | $95.60M | 32.56% | 9.19% | 6.83% |
| 2016 | $1.51B | $143.60M | 33.21% | 13.04% | 9.52% |
| 2017 | $1.60B | $150.70M | 32.06% | 14.31% | 9.42% |
| 2018 | $1.72B | $206.90M | 31.80% | 14.83% | 12.04% |
| 2019 | $1.84B | $241.70M | 33.02% | 16.12% | 13.11% |
| 2020 | $2.15B | $346.20M | 35.77% | 19.52% | 16.13% |
| 2021 | $2.83B | $661.80M | 41.45% | 26.80% | 23.38% |
| 2022 | $2.89B | $585.90M | 39.47% | 26.46% | 20.30% |
| 2023 | $2.95B | $593.40M | 38.38% | 24.09% | 20.11% |
| 2024 | $2.89B | $492.70M | 34.65% | 20.56% | 17.03% |
| 2025 | $3.07B | $493.70M | 35.89% | 20.09% | 16.06% |